| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.37B | -16.6% |
| Cost of Revenue | $1.34B | -30.1% |
| R&D Expense | $334.5M | +0.5% |
| SG&A Expense | $892.0M | -8.7% |
| Operating Income | -$260.8M | +45.1% |
| Interest Expense | $157.6M | +43.1% |
| Pre-tax Income | $367.1M | +124.1% |
| Income Tax | $108.8M | +132.9% |
| Net Income | $265.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.30B | -8.5% |
| Short-term Investments | $149.0M | -37.8% |
| Accounts Receivable | $536.6M | -11.7% |
| Current Assets | $2.24B | -12.5% |
| Total Assets | $10.37B | -0.2% |
| Current Liabilities | $950.5M | -12.0% |
| Long-term Debt | $2.04B | -1.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $141.4M | +1.2% |
| +122.7% |
| EPS (Basic) | $3.07 | +122.7% |
| EPS (Diluted) | $2.97 | +121.9% |
| Stockholders' Equity |
| $6.08B |
| +2.5% |